Edition:
United States

Acorda Therapeutics Inc (ACOR.OQ)

ACOR.OQ on NASDAQ Stock Exchange Global Select Market

19.78USD
16 Nov 2018
Change (% chg)

$0.81 (+4.27%)
Prev Close
$18.97
Open
$18.86
Day's High
$19.86
Day's Low
$18.68
Volume
183,904
Avg. Vol
228,081
52-wk High
$36.25
52-wk Low
$15.65

Select another date:

Mon, Sep 10 2018

U.S. appeals court invalidates Acorda patents on MS drug

A U.S. appeals court on Monday invalidated Acorda Therapeutics Inc patents covering its multiple sclerosis drug Ampyra, opening the door to generic competition for the company's flagship product.

UPDATE 1-U.S. appeals court invalidates Acorda patents on MS drug

Sept 10 A U.S. appeals court on Monday invalidated Acorda Therapeutics Inc patents covering its multiple sclerosis drug Ampyra, opening the door to generic competition for the company's flagship product.

UPDATE 2-Acorda loses bid for U.S. court order halting generic Ampyra sales

July 25 A U.S. appeals court on Wednesday denied a request by Acorda Therapeutics Inc for a temporary court order blocking generic drug companies from launching lower-cost versions of its multiple sclerosis drug Ampyra.

Acorda loses bid for U.S. court order halting generic Ampyra sales

A U.S. appeals court on Wednesday denied a request by Acorda Therapeutics Inc for a temporary court order blocking generic drug companies from launching lower-cost versions of its multiple sclerosis drug Ampyra.

Drugmakers oppose Acorda's bid to block generic MS drug's release

Three generic drug manufacturers are urging a federal appeals court to reject Acorda Therapeutics Inc's "extraordinary" request for an order blocking them from launching a generic version of multiple sclerosis drug Ampyra before the case is decided.

Select another date: